NumerixS Investment Technologies’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-20,366
Closed -$1.31M 519
2020
Q2
$1.31M Buy
+20,366
New +$1.12M 0.37% 51
2020
Q1
Sell
-28,892
Closed -$565K 1170
2019
Q4
$565K Buy
28,892
+8,864
+44% +$157K 0.11% 209
2019
Q3
$319K Buy
20,028
+3,065
+18% +$45.3K 0.08% 248
2019
Q2
$248K Buy
+16,963
New +$364K 0.07% 343

Other funds holding MRNA

NumerixS Investment Technologies's MRNA Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Moderna (MRNA) in Q3 2020, closing a stake of 20,366 shares — an estimated $1.31M sold.

NumerixS Investment Technologies first reported a position in MRNA in Q2 2019 and held it in 4 quarters. The position peaked at $1.31M in Q2 2020. 547 funds tracked by Wall St. Rank hold MRNA as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Moderna position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 20,366 Moderna shares in Q3 2020, an estimated $1.31M.
  • NumerixS Investment Technologies first reported a position in Moderna in Q2 2019 and held it in 4 quarters.
  • NumerixS Investment Technologies's Moderna position peaked at $1.31M in Q2 2020.
  • 547 funds tracked by Wall St. Rank held Moderna as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.